Rhythm control or rate control?
AFFIRM - no survival benefit between rhythm vs rate. Rhythm towards in mortality
AF-CHF - no reduction of mortality in patients with HFrEF
HOT CAFÉ – No sig survival benefits
EAST-AFNET 4
Early Rhythm-Control Therapy in Patients with Atrial Fibrillation
Early rhythm-control therapy was associated with a lower risk of cardiovascular outcomes than usual care among patients with early atrial fibrillation and cardiovascular conditions.
Target heart rate?
RACE II - strict rate control(<80) vs lenient rate control(<110). similar outcome.
Warfarin or antiplatelets?
SPAF
In patients with AF aspirin alone and warfarin alone both reduce stroke risk.
Warfarin is better.
ACTIVE W
ASA+Clopidogrel is inferior to warfarin
ACTIVE A
ASA+Clopidogrel is better than ASA alone for patients with contraindications for warfarin